Day: January 6, 2021

OCALA, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced that the active AMP-511 Expanded Access Program (EAP) has dosed its first COVID-19 “Long Hauler” patient with the drug Ampligen (rintatolimod), marking a significant milestone in AIM’s efforts to develop an effective therapeutic for people suffering from post-COVID-19 infection chronic fatigue-like symptoms. Additional patients are in the process of being enrolled. The Company also reported it will host an investor conference call on January 12, 2020 at 11AM ET to discuss the AMP-511 trial, believed to be the first clinical trial to treat a patient with COVID-19-induced chronic fatigue-like symptoms, as well as to provide an overall status update on the Company.The Ampligen EAP protocol is authorized at any one time to enroll up...

CHARLOTTE, N.C., Jan. 06, 2021 (GLOBE NEWSWIRE) — Glatfelter Corporation (NYSE: GLT), a leading global supplier of engineered materials, today announced the signing of a definitive agreement to purchase Georgia-Pacific’s U.S. nonwovens business for $175 million, subject to customary post-closing purchase price adjustments.Glatfelter will acquire Georgia-Pacific’s Mount Holly, North Carolina, airlaid manufacturing business and an R&D pilot line for nonwovens product development in Memphis, Tennessee, which collectively employ approximately 150 people. The Mount Holly facility has a capacity of 37,000 metric tons and produces high-quality airlaid products focused on wipes and tabletop materials. The R&D pilot line and additional technical resources will enhance ongoing innovation efforts.“The agreement to acquire Georgia-Pacific’s...

WALTHAM, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system, today announced that it has entered into a securities purchase agreement in connection with a private placement (the “Private Placement”) with an affiliate of Armistice Capital, LLC (“Armistice”) for aggregate gross proceeds of approximately $8.0 million. The Private Placement is expected to close on or about January 6, 2021, subject to the satisfaction of customary closing conditions.In accordance with the Purchase Agreement, the Company will issue to Armistice an aggregate of (i) 1,531,101 shares (the “Shares”) of the Company’s common stock, par value...

6 January 2021LEI: 2138003QW2ZAYZODBU23LSE Code: 3USSWISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE S&P 500 3X  DAILY SHORT SECURITIESRESULTS OF MEETING OF THE ETP SECURITYHOLDERSWisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”) wishes to announce that the Extraordinary Resolution regarding the reduction in the principal amount of the WisdomTree S&P 500 3X Daily Short Securities (the “Affected Securities”, with ISIN IE00B8K7KM88) from USD 0.2 to USD 0.02, as set out in a notice to holders of the Affected Securities dated 17 November 2020, was not passed at the adjourned meeting of the holders of the Affected Securities held at 11am on 6 January 2021.

CHICAGO, Jan. 06, 2021 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) will publish its financial results for the fourth quarter ended December 31, 2020, in a press release to be issued by 6:00 a.m. Central Time (CT) on Tuesday, February 16, 2021. The company will hold a conference call on the same day at 8:30 a.m. Central Time (CT) to discuss its financial results. The press release and a live webcast of the earnings conference call will be available on the TransUnion Investor Relations website at http://www.transunion.com/tru.About TransUnionTransUnion is a global information and insights company that makes trust possible in the modern economy. We do this by providing a comprehensive picture of each person so they can be reliably and safely represented in the marketplace. As a result, businesses and consumers can transact with confidence...

WEST PALM BEACH, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) — Ocwen Financial Corporation (NYSE: OCN) (“Ocwen” or the “Company”), a leading non-bank mortgage servicer and originator, today issued the following statement in response to the mediator’s notice that the Company’s court-ordered mediation with the Consumer Financial Protection Bureau (“CFPB” or “Bureau”) had concluded. The parties were unable to reach a settlement related to the lawsuit filed by the CFPB in 2017 against the Company regarding certain legacy servicing activities.“We are disappointed that settlement discussions with the CFPB did not resolve this matter, in particular since we have resolved all state regulatory actions filed against Ocwen in April 2017, most recently through a settlement reached with the State of Florida in October 2020. We engaged with the Bureau...

TORONTO, Jan. 06, 2021 (GLOBE NEWSWIRE) — Discovery Metals Corp. (TSX-V: DSV, OTCQX: DSVMF) (“Discovery” or the “Company”) is pleased to announce results from 10 diamond drill holes targeting the Parcionera and Josefina high-grade vein trends at its flagship Cordero project (“Cordero” or “the Project”) located in Chihuahua State, Mexico. Multiple vein trends with a combined strike extent of more than 5 km flank the higher-grade bulk-tonnage domain at Cordero; the Parcionera and Josefina vein trends currently represent approximately 2 km of this strike extent.Highlight intercepts include:Parcionera Vein TrendHole C20-362: 4.4 m averaging 524 grams per tonne silver equivalent (“g/t AgEq1”) from 53.9 m (246 g/t Ag, 0.39 g/t gold (“Au”), 6.5% lead (“Pb”) and 0.4% zinc (“Zn”)) within a 37.1 m interval averaging 113 g/t AgEq1 (47 g/t...

ST. LOUIS, Jan. 06, 2021 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced the signing of a multi-year agreement with ICE Norway for the deployment of Amdocs ActixOne and Amdocs TechInsights software solutions to support its network expansion and digital transformation initiatives. ICE has a range of mobile service offerings and is in the midst of a significant network buildout program for its existing and newly acquired 5G spectrum. Amdocs systems will help automate activities for planning, building, launching, monitoring and optimizing RAN (Radio Access Network) sites. Additionally, Amdocs’ analytics-driven platform will aid in predicting network issues and prioritizing remediation actions based on key business parameters.“By continuing to...

RAD011 is a pivotal-trial ready synthetic cannabidiol oral solution with potential utilization in multiple endocrine and metabolic orphan diseasesPrader-Willi syndrome (“PWS”) will be the initial indication, which has been granted Orphan Drug and Fast Track Designation by the FDAAcquisition and associated PWS trial costs to be funded from existing operationsManagement to host conference call and webcast this morning at 8:15 a.m. ETBOSTON, Jan. 06, 2021 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced a definitive agreement to acquire the global development and commercialization rights to Benuvia Therapeutics Inc.’s (“Benuvia”) synthetic cannabidiol oral solution (“RAD011”). The Company plans to initiate a pivotal Phase 2/3 study for patients with Prader-Willi syndrome (“PWS”) in the...

THORNTON, CO, Jan. 06, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Ascent Solar Technologies, Inc. (OTCQB: ASTI), a developer and manufacturer of state-of-the-art, lightweight, and flexible thin-film photovoltaic (PV) solutions, announces the completion of Tranche 2 of the Series 1A Preferred Stock.On September 22, 2020, the Company entered into a securities purchase agreement (“Series 1A SPA”) with Crowdex Investment LLC, a private investor (“Crowdex”) and sold 2,000 shares of Series 1A Preferred Stock to Crowdex in exchange for $2,000,000 of gross proceeds at initial Tranche 1 closing.On November 27, 2020, the Company issued to Crowdex a $500,000 Unsecured Convertible Promissory Note (“Note”) in a private placement and received $500,000 of gross proceeds from the offering of the Note. On December 31, 2020, the Company sold...